224 related articles for article (PubMed ID: 15958052)
21. Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.
Fukamachi K; Han BS; Kim CK; Takasuka N; Matsuoka Y; Matsuda E; Yamasaki T; Tsuda H
Cancer Sci; 2004 May; 95(5):404-10. PubMed ID: 15132767
[TBL] [Abstract][Full Text] [Related]
22. Possible enhancing activity of diacylglycerol on 4-nitroquinoline 1-oxide induced carcinogenesis of the tongue in human c-Ha-ras proto-oncogene transgenic rats.
Tsuda H; Iigo M; Takasuka N; Ueda S; Ohshima Y; Fukamachi K; Shirai T; Hirano S; Matsuda E; Wakabayashi K
Food Chem Toxicol; 2007 Jun; 45(6):1013-9. PubMed ID: 17258375
[TBL] [Abstract][Full Text] [Related]
23. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
[TBL] [Abstract][Full Text] [Related]
24. Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats.
Naito A; Suzuki A; Ueda S; Nomoto H; Toriyama-Baba H; Asamoto M; Tsuda H
Cancer Sci; 2004 May; 95(5):399-403. PubMed ID: 15132766
[TBL] [Abstract][Full Text] [Related]
25. Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic rats.
Hamaguchi T; Matsuoka Y; Kawaguchi H; Fukamachi K; Takasuka N; Ueda S; Shimizu K; Ohki M; Kusunoki M; Sakakura T; Yoshida H; Tsuda H
Breast Cancer Res Treat; 2004 Jan; 83(1):43-56. PubMed ID: 14997054
[TBL] [Abstract][Full Text] [Related]
26. Structural analysis of the ras transgene in MMTV/v-Ha-ras transgenic mice.
DeWille JW; Farmer SJ
Lab Anim Sci; 1994 Apr; 44(2):131-4. PubMed ID: 8028274
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
[TBL] [Abstract][Full Text] [Related]
28. Timing of supplementation with the antioxidant N-acetyl-L-cysteine reduces tumor multiplicity in novel, cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) transgenic mice but has no impact on malignant progression.
Martin KR; Saulnier MJ; Kari FW; Barrett JC; French JE
Nutr Cancer; 2002; 43(1):59-66. PubMed ID: 12467136
[TBL] [Abstract][Full Text] [Related]
29. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.
Vitale-Cross L; Amornphimoltham P; Fisher G; Molinolo AA; Gutkind JS
Cancer Res; 2004 Dec; 64(24):8804-7. PubMed ID: 15604235
[TBL] [Abstract][Full Text] [Related]
30. Induction of a novel histone deacetylase 1/c-Myc/Mnt/Max complex formation is implicated in parity-induced refractoriness to mammary carcinogenesis.
Matsuoka Y; Fukamachi K; Uehara N; Tsuda H; Tsubura A
Cancer Sci; 2008 Feb; 99(2):309-15. PubMed ID: 18271930
[TBL] [Abstract][Full Text] [Related]
31. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
[TBL] [Abstract][Full Text] [Related]
32. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
33. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
34. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.
Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H
Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805
[TBL] [Abstract][Full Text] [Related]
35. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
[TBL] [Abstract][Full Text] [Related]
38. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
[TBL] [Abstract][Full Text] [Related]
39. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
40. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.
Liu ML; Von Lintig FC; Liyanage M; Shibata MA; Jorcyk CL; Ried T; Boss GR; Green JE
Oncogene; 1998 Nov; 17(18):2403-11. PubMed ID: 9811472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
